Liver Health: ASAT, ALAT and Oral Steroids

The mechanism: why orals are hepatotoxic

For a steroid to survive first-pass hepatic metabolism (the liver process that breaks down ingested substances before they reach systemic circulation), it has to be 17-alpha-alkylated (17α-aa) — a methyl group added at position 17 of the steroid nucleus. This chemical modification makes the oral route possible… at the cost of a heavy load on the liver, which has to metabolize a modified molecule resistant to its own degradation pathways.

Clinical consequences observed: rising transaminases (AST, ALT), bile function impairment (cholestasis), possible bilirubin rise, and more rarely (but documented on long high-dose use) hepatic peliosis, adenomas and serious hepatic damage ^[2]. The risk is clearly dose- and duration-dependent ^[1].

Oral compounds and their hepatic footprint

• Anadrol (oxymetholone). Often cited as one of the most toxic orals for the liver. See the Anadrol page.
• Dianabol (methandrostenolone). Significant hepatotoxicity at standard dose and duration.
• Winstrol (stanozolol). Hepatotoxic, plus the most pronounced lipid impact.
• Anavar (oxandrolone). Considered the best-tolerated oral on the liver at standard doses, but not inert either.
• Turinabol (chlorodehydromethyltestosterone). Moderate hepatotoxicity at standard dose, duration to keep limited.

Liver markers and their thresholds

AST vs ALT: the training trap

AST is in the liver but also in muscle. After an intense training session (heavy lifting, hard hypertrophy work), AST can be elevated without any liver issue. That is why, to evaluate hepatic stress, you look mainly at ALT (more liver-specific) and GGT alongside ^[3]. A high AST with normal ALT and GGT points to a muscular origin.

Warning thresholds

• 1 to 3× the reference range. Monitor; common under orals; recheck at 2–3 weeks.
• > 3× the reference range. Alert: consider stopping the oral and re-consulting ^[5].
• > 5× the reference range. Stop the oral and seek medical attention promptly; recheck within 1–2 weeks.
• Elevated bilirubin or ALP + jaundice, dark urine. Immediate stop of the oral and prompt consult — signs of cholestasis.

Best practices to limit hepatic load

1. Limit duration

The commonly accepted rule: 4 to 6 weeks maximum on an oral, exceptionally 8 weeks for the best-tolerated compounds (Anavar) in a well-controlled cycle. Past that, the hepatic risk/benefit ratio deteriorates clearly, without proportional muscle gain ^[2].

2. Do not stack orals

Stacking two 17α-alkylated orals (for example Dianabol + Winstrol, or Anavar + Winstrol) doubles the liver load with no major muscle benefit. This is a practice to avoid, especially for beginners and intermediates ^[4].

3. Supplementation: TUDCA and NAC

• TUDCA (tauroursodeoxycholic acid). The most systematically cited supplement. Helps thin bile and protect hepatocytes from the cholestatic stress of 17α-aa compounds. Usual dose: 250 to 500 mg/day for the duration of the oral.
• NAC (N-acetylcysteine). Precursor of glutathione, the liver's major antioxidant. Usual dose: 600 to 1200 mg/day.
• Milk thistle (silymarin). Documented hepatoprotective effect but often judged inferior to TUDCA for the specific 17α-aa context. Can be added; not a substitute.

4. Alcohol and co-medications

• Alcohol: avoid during the oral phase. Alcohol stacks with the hepatic load of orals and meaningfully raises risk.
• Limit acetaminophen (Tylenol) during the oral phase — it is also hepatotoxic at cumulative dose.
• Flag hepatotoxic co-medications (long-term antibiotics, prolonged NSAIDs, etc.) to your doctor if you are being followed.

Liver monitoring schedule

• Baseline before cycle: AST, ALT, GGT, ALP, total bilirubin.
• During the oral phase: check toward the end of week 4 if the oral runs 6 to 8 weeks.
• End of cycle: 1 to 2 weeks after fully stopping the oral.
• Post-PCT: included in the global recovery panel.

For the global schedule (CBC, hormonal, lipid, hepatic), see blood test schedule for a cycle. Lab PDFs can be imported into AnaProtoKol's blood work feature (8 panels, 59 markers) to track transaminases over time with the baseline as reference.

Frequently asked questions